Literature DB >> 30927073

Impact of 9q deletions on the classification of patients with acute myeloid leukemia.

Bettina Balk1, Torsten Haferlach1, Manja Meggendorfer1, Wolfgang Kern1, Claudia Haferlach1, Anna Stengel2.   

Abstract

Entities:  

Keywords:  AML; NPM1; RUNX1-RUNX1T1; del(9q)

Mesh：

Substances：

Year:  2019        PMID： 30927073     DOI： 10.1007/s00432-019-02908-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  11 in total

1.  Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.

Authors:  Tobias Herold; Klaus H Metzeler; Sebastian Vosberg; Luise Hartmann; Vindi Jurinovic; Sabrina Opatz; Nikola P Konstandin; Stephanie Schneider; Evelyn Zellmeier; Bianka Ksienzyk; Alexander Graf; Stefan Krebs; Helmut Blum; Maria Cristina Sauerland; Thomas Büchner; Wolfgang E Berdel; Bernhard J Wörmann; Ulrich Mansmann; Wolfgang Hiddemann; Stefan K Bohlander; Karsten Spiekermann; Philipp A Greif
Journal:  Genes Chromosomes Cancer       Date:  2016-10-25       Impact factor: 5.006

2.  Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

Authors:  C Schoch; S Schnittger; S Bursch; D Gerstner; A Hochhaus; U Berger; R Hehlmann; W Hiddemann; T Haferlach
Journal:  Leukemia       Date:  2002-01       Impact factor: 11.528

3.  A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.

Authors:  S E Langabeer; D Grimwade; H Walker; J R Rogers; A K Burnett; A H Goldstone; D C Linch
Journal:  Br J Haematol       Date:  1998-05       Impact factor: 6.998

4.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

5.  Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.

Authors:  Isabel S Naarmann-de Vries; Yvonne Sackmann; Felicitas Klein; Antje Ostareck-Lederer; Dirk H Ostareck; Edgar Jost; Gerhard Ehninger; Tim H Brümmendorf; Gernot Marx; Christoph Röllig; Christian Thiede; Martina Crysandt
Journal:  Leuk Res       Date:  2018-11-17       Impact factor: 3.156

6.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Authors:  R Coleman Lindsley; Brenton G Mar; Emanuele Mazzola; Peter V Grauman; Sarah Shareef; Steven L Allen; Arnaud Pigneux; Meir Wetzler; Robert K Stuart; Harry P Erba; Lloyd E Damon; Bayard L Powell; Neal Lindeman; David P Steensma; Martha Wadleigh; Daniel J DeAngelo; Donna Neuberg; Richard M Stone; Benjamin L Ebert
Journal:  Blood       Date:  2014-12-30       Impact factor: 22.113

Review 7.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

Review 8.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

9.  Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.

Authors:  Farshid Dayyani; Jianfeng Wang; Jing-Ruey J Yeh; Eun-Young Ahn; Erica Tobey; Dong-Er Zhang; Irwin D Bernstein; Randall T Peterson; David A Sweetser
Journal:  Blood       Date:  2008-02-07       Impact factor: 22.113

Review 10.  Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.

Authors:  David Grimwade; Adam Ivey; Brian J P Huntly
Journal:  Blood       Date:  2015-12-10       Impact factor: 25.476
View more
  1 in total

Review 1.  Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.

Authors:  Aliaa Arina Rosli; Adam Azlan; Yaashini Rajasegaran; Yee Yik Mot; Olaf Heidenreich; Narazah Mohd Yusoff; Emmanuel Jairaj Moses
Journal:  Clin Exp Med       Date:  2022-10-13       Impact factor: 5.057
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.